Triple

T20061751
Position Surface form Disambiguated ID Type / Status
Subject BEACOPP regimen E499491 entity
Predicate componentDrug P82705 FINISHED
Object procarbazine
Procarbazine is an oral alkylating chemotherapy agent primarily used in combination regimens to treat Hodgkin lymphoma and certain brain tumors.
 E1408632 NE FINISHED

How this triple was built (4 steps)

Every LLM step that produced this triple, in pipeline order — named-entity classification, the disambiguation choices (the exact options shown, with the pick highlighted), and the generated description. The batch + timestamp of each is in the Provenance table below.

NER Named-entity recognition gpt-5-mini
Instruction
Given a phrase, classify it is english named entity (e.g., persons, organizations, works of art) in Latin script, or not (e.g., literals, dates, URLs, verbose phrases). For disambiguation, the statement where the phrase occurs as object is also given. Please return a JSON object with `phrase` (string, the phrase being analyzed) and `is_ne` (boolean, indicating whether the phrase is a Named Entity).
Input
Phrase: procarbazine | Statement: [BEACOPP regimen, componentDrug, procarbazine]
NED1 Entity disambiguation (via context triple) gpt-5-mini-2025-08-07 
Target entity: procarbazine
Context triple: [BEACOPP regimen, componentDrug, procarbazine]
  • A. cyclophosphamide
    Cyclophosphamide is a widely used alkylating chemotherapy and immunosuppressive drug commonly employed in the treatment of cancers and autoimmune diseases.
  • B. Bicutan
    Bicutan is a district in Taguig, Metro Manila, Philippines, known for its residential areas, government offices, and commercial developments.
  • C. mitoxantrone
    Mitoxantrone is an anthracenedione chemotherapeutic agent used primarily to treat certain cancers and multiple sclerosis by intercalating DNA and inhibiting topoisomerase II.
  • D. vincristine
    Vincristine is a chemotherapy medication, specifically a vinca alkaloid, widely used in combination regimens to treat various cancers including lymphomas and leukemias.
  • E. irinotecan
    Irinotecan is a chemotherapy drug, specifically a topoisomerase I inhibitor, commonly used to treat colorectal and other cancers.
  • F. None of above. chosen
  • G. Unsure - the case is ambiguous/there is not enough information to decide.
NEDg Description generation gpt-5.1
Instruction
Generate a one-sentence description of the target entity. 
You are given a context triple in the form (subject, predicate, object), where the object is the target entity. 
# Instructions
Use the triple to infer relevant information about the entity. Describe the entity based on what is most defining, well-known. 
Avoid repeating the information from the triple, unless really essential.
# Response Format
Return only the sentence: "Description: [one-sentence description of the target entity]"
Input
Entity: procarbazine
Triple: [BEACOPP regimen, componentDrug, procarbazine]
Generated description
Procarbazine is an oral alkylating chemotherapy agent primarily used in combination regimens to treat Hodgkin lymphoma and certain brain tumors.
NED2 Entity disambiguation (via description) gpt-5-mini-2025-08-07 
Target entity: procarbazine
Target entity description: Procarbazine is an oral alkylating chemotherapy agent primarily used in combination regimens to treat Hodgkin lymphoma and certain brain tumors.
  • A. cyclophosphamide
    Cyclophosphamide is a widely used alkylating chemotherapy and immunosuppressive drug commonly employed in the treatment of cancers and autoimmune diseases.
  • B. Bicutan
    Bicutan is a district in Taguig, Metro Manila, Philippines, known for its residential areas, government offices, and commercial developments.
  • C. mitoxantrone
    Mitoxantrone is an anthracenedione chemotherapeutic agent used primarily to treat certain cancers and multiple sclerosis by intercalating DNA and inhibiting topoisomerase II.
  • D. vincristine
    Vincristine is a chemotherapy medication, specifically a vinca alkaloid, widely used in combination regimens to treat various cancers including lymphomas and leukemias.
  • E. irinotecan
    Irinotecan is a chemotherapy drug, specifically a topoisomerase I inhibitor, commonly used to treat colorectal and other cancers.
  • F. None of above. chosen

Provenance (5 batches)

The batch behind each pipeline step, in order, with when it ran. Timestamps are batch-level — stages were processed in waves, so the object chain (NER → NED1 → NEDg → NED2) reads in order, but predicate / elicitation batches can sit in a different wave.

Step Stage Batch ID Status When
creating Elicitation batch_69da6276bcf48190aabbf279192a5fb4 completed April 11, 2026, 3:02 p.m.
NER Named-entity recognition batch_69e6637601dc8190a07fc20844093cb7 completed April 20, 2026, 5:33 p.m.
NED1 Entity disambiguation (via context triple) batch_6a0816108a408190a62065447c1045bb completed May 16, 2026, 7 a.m.
NEDg Description generation batch_6a0816fe5788819095736bd9464cfed5 completed May 16, 2026, 7:04 a.m.
NED2 Entity disambiguation (via description) batch_6a08179df70c81908ea5bc596a8ba756 completed May 16, 2026, 7:07 a.m.
Created at: April 11, 2026, 3:38 p.m.